Alpha-single chains of collagen type VI inhibit the fibrogenic effects of triple helical collagen VI in hepatic stellate cells.

The interaction of extracellular matrix (ECM) components with hepatic stellate cells (HSCs) is thought to perpetuate fibrosis by stimulating signaling pathways that drive HSC activation, survival and proliferation. Consequently, disrupting the interaction between ECM and HSCs is considered a therape...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Christian Freise, Hyunho Lee, Christopher Chronowski, Doug Chan, Jessica Cziomer, Martin Rühl, Tarkan Dagdelen, Maik Lösekann, Ulrike Erben, Andre Catic, Werner Tegge, Detlef Schuppan, Rajan Somasundaram, Ergun Sahin
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/c0592e5b855b410eba7919d3c998a0cf
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:c0592e5b855b410eba7919d3c998a0cf
record_format dspace
spelling oai:doaj.org-article:c0592e5b855b410eba7919d3c998a0cf2021-12-02T20:04:45ZAlpha-single chains of collagen type VI inhibit the fibrogenic effects of triple helical collagen VI in hepatic stellate cells.1932-620310.1371/journal.pone.0254557https://doaj.org/article/c0592e5b855b410eba7919d3c998a0cf2021-01-01T00:00:00Zhttps://doi.org/10.1371/journal.pone.0254557https://doaj.org/toc/1932-6203The interaction of extracellular matrix (ECM) components with hepatic stellate cells (HSCs) is thought to perpetuate fibrosis by stimulating signaling pathways that drive HSC activation, survival and proliferation. Consequently, disrupting the interaction between ECM and HSCs is considered a therapeutical avenue although respective targets and underlying mechanisms remain to be established. Here we have interrogated the interaction between type VI collagen (CVI) and HSCs based on the observation that CVI is 10-fold upregulated during fibrosis, closely associates with HSCs in vivo and promotes cell proliferation and cell survival in cancer cell lines. We exposed primary rat HSCs and a rat hepatic stellate cell line (CFSC) to soluble CVI and determined the rate of proliferation, apoptosis and fibrogenesis in the absence of any additional growth factors. We find that CVI in nanomolar concentrations prevents serum starvation-induced apoptosis. This potent anti-apoptotic effect is accompanied by induction of proliferation and acquisition of a pronounced pro-fibrogenic phenotype characterized by increased α-smooth muscle actin, TGF-β, collagen type I and TIMP-1 expression and diminished proteolytic MMP-13 expression. The CVI-HSC interaction can be disrupted with the monomeric α2(VI) and α3(VI) chains and abrogates the activating CVI effects. Further, functional relevant α3(VI)-derived 30 amino acid peptides lead to near-complete inhibition of the CVI effect. In conclusion, CVI serves as a potent mitogen and activating factor for HSCs. The antagonistic effects of the CVI monomeric chains and peptides point to linear peptide sequences that prevent activation of CVI receptors which may allow a targeted antifibrotic therapy.Christian FreiseHyunho LeeChristopher ChronowskiDoug ChanJessica CziomerMartin RühlTarkan DagdelenMaik LösekannUlrike ErbenAndre CaticWerner TeggeDetlef SchuppanRajan SomasundaramErgun SahinPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 16, Iss 9, p e0254557 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Christian Freise
Hyunho Lee
Christopher Chronowski
Doug Chan
Jessica Cziomer
Martin Rühl
Tarkan Dagdelen
Maik Lösekann
Ulrike Erben
Andre Catic
Werner Tegge
Detlef Schuppan
Rajan Somasundaram
Ergun Sahin
Alpha-single chains of collagen type VI inhibit the fibrogenic effects of triple helical collagen VI in hepatic stellate cells.
description The interaction of extracellular matrix (ECM) components with hepatic stellate cells (HSCs) is thought to perpetuate fibrosis by stimulating signaling pathways that drive HSC activation, survival and proliferation. Consequently, disrupting the interaction between ECM and HSCs is considered a therapeutical avenue although respective targets and underlying mechanisms remain to be established. Here we have interrogated the interaction between type VI collagen (CVI) and HSCs based on the observation that CVI is 10-fold upregulated during fibrosis, closely associates with HSCs in vivo and promotes cell proliferation and cell survival in cancer cell lines. We exposed primary rat HSCs and a rat hepatic stellate cell line (CFSC) to soluble CVI and determined the rate of proliferation, apoptosis and fibrogenesis in the absence of any additional growth factors. We find that CVI in nanomolar concentrations prevents serum starvation-induced apoptosis. This potent anti-apoptotic effect is accompanied by induction of proliferation and acquisition of a pronounced pro-fibrogenic phenotype characterized by increased α-smooth muscle actin, TGF-β, collagen type I and TIMP-1 expression and diminished proteolytic MMP-13 expression. The CVI-HSC interaction can be disrupted with the monomeric α2(VI) and α3(VI) chains and abrogates the activating CVI effects. Further, functional relevant α3(VI)-derived 30 amino acid peptides lead to near-complete inhibition of the CVI effect. In conclusion, CVI serves as a potent mitogen and activating factor for HSCs. The antagonistic effects of the CVI monomeric chains and peptides point to linear peptide sequences that prevent activation of CVI receptors which may allow a targeted antifibrotic therapy.
format article
author Christian Freise
Hyunho Lee
Christopher Chronowski
Doug Chan
Jessica Cziomer
Martin Rühl
Tarkan Dagdelen
Maik Lösekann
Ulrike Erben
Andre Catic
Werner Tegge
Detlef Schuppan
Rajan Somasundaram
Ergun Sahin
author_facet Christian Freise
Hyunho Lee
Christopher Chronowski
Doug Chan
Jessica Cziomer
Martin Rühl
Tarkan Dagdelen
Maik Lösekann
Ulrike Erben
Andre Catic
Werner Tegge
Detlef Schuppan
Rajan Somasundaram
Ergun Sahin
author_sort Christian Freise
title Alpha-single chains of collagen type VI inhibit the fibrogenic effects of triple helical collagen VI in hepatic stellate cells.
title_short Alpha-single chains of collagen type VI inhibit the fibrogenic effects of triple helical collagen VI in hepatic stellate cells.
title_full Alpha-single chains of collagen type VI inhibit the fibrogenic effects of triple helical collagen VI in hepatic stellate cells.
title_fullStr Alpha-single chains of collagen type VI inhibit the fibrogenic effects of triple helical collagen VI in hepatic stellate cells.
title_full_unstemmed Alpha-single chains of collagen type VI inhibit the fibrogenic effects of triple helical collagen VI in hepatic stellate cells.
title_sort alpha-single chains of collagen type vi inhibit the fibrogenic effects of triple helical collagen vi in hepatic stellate cells.
publisher Public Library of Science (PLoS)
publishDate 2021
url https://doaj.org/article/c0592e5b855b410eba7919d3c998a0cf
work_keys_str_mv AT christianfreise alphasinglechainsofcollagentypeviinhibitthefibrogeniceffectsoftriplehelicalcollagenviinhepaticstellatecells
AT hyunholee alphasinglechainsofcollagentypeviinhibitthefibrogeniceffectsoftriplehelicalcollagenviinhepaticstellatecells
AT christopherchronowski alphasinglechainsofcollagentypeviinhibitthefibrogeniceffectsoftriplehelicalcollagenviinhepaticstellatecells
AT dougchan alphasinglechainsofcollagentypeviinhibitthefibrogeniceffectsoftriplehelicalcollagenviinhepaticstellatecells
AT jessicacziomer alphasinglechainsofcollagentypeviinhibitthefibrogeniceffectsoftriplehelicalcollagenviinhepaticstellatecells
AT martinruhl alphasinglechainsofcollagentypeviinhibitthefibrogeniceffectsoftriplehelicalcollagenviinhepaticstellatecells
AT tarkandagdelen alphasinglechainsofcollagentypeviinhibitthefibrogeniceffectsoftriplehelicalcollagenviinhepaticstellatecells
AT maiklosekann alphasinglechainsofcollagentypeviinhibitthefibrogeniceffectsoftriplehelicalcollagenviinhepaticstellatecells
AT ulrikeerben alphasinglechainsofcollagentypeviinhibitthefibrogeniceffectsoftriplehelicalcollagenviinhepaticstellatecells
AT andrecatic alphasinglechainsofcollagentypeviinhibitthefibrogeniceffectsoftriplehelicalcollagenviinhepaticstellatecells
AT wernertegge alphasinglechainsofcollagentypeviinhibitthefibrogeniceffectsoftriplehelicalcollagenviinhepaticstellatecells
AT detlefschuppan alphasinglechainsofcollagentypeviinhibitthefibrogeniceffectsoftriplehelicalcollagenviinhepaticstellatecells
AT rajansomasundaram alphasinglechainsofcollagentypeviinhibitthefibrogeniceffectsoftriplehelicalcollagenviinhepaticstellatecells
AT ergunsahin alphasinglechainsofcollagentypeviinhibitthefibrogeniceffectsoftriplehelicalcollagenviinhepaticstellatecells
_version_ 1718375566276558848